Currently, there are 5.7 million Americans living with Alzheimer’s disease and over 15 million people caring for them. It is the only disease among the nation’s top ten leading causes of death that has no treatment, prevention or cure. But, here at the University of Wisconsin, we believe that memories matter. Our extensive research program is conducting basic, translational, clinical, and health services research. And, as the first and only combined School of Medicine and Public Health in the country, our faculty and physicians are committed to ensuring that the discoveries made here improve patient outcomes within the community, across the state and beyond.
In order to advance our work, the UW Initiative to End Alzheimer’s is looking to identify philanthropic support to do the following:
- Invest in additional outreach and recruitment efforts in order to increase the number of minority research participants
- Support Dr. Subhojit Roy and his laboratory in their continued work utilizing gene editing to stop the progression of Alzheimer’s disease
- Acquire the remaining funding needed to purchase a state-of-the-art positron emission tomography (PET/CT) scanner allowing our imaging scientists to achieve much more stable, reliable, and accurate data
- Investigate blood-based, cerebrospinal fluid based, and other tissue biomarkers not currently being analyzed
- Accelerate work of Dr. Puglielli and his team in their continued discovery of drug compounds that can clear toxic protein deposits thought to cause Alzheimer’s disease from the brain
- Conduct imaging on additional cohort study participants to aid in the discovery of the origins of the disease